ES2176277T3 - Derivados heterociclicos carboxialquilicos. - Google Patents

Derivados heterociclicos carboxialquilicos.

Info

Publication number
ES2176277T3
ES2176277T3 ES95120208T ES95120208T ES2176277T3 ES 2176277 T3 ES2176277 T3 ES 2176277T3 ES 95120208 T ES95120208 T ES 95120208T ES 95120208 T ES95120208 T ES 95120208T ES 2176277 T3 ES2176277 T3 ES 2176277T3
Authority
ES
Spain
Prior art keywords
carboxialquilic
compounds
heterociclic
derivatives
heterociclic derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95120208T
Other languages
English (en)
Inventor
Takayuki Kotani
Kaoru Okamoto
Yasuhiro Nagaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2176277T3 publication Critical patent/ES2176277T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE PROPORCIONA UN COMPUESTO REPRESENTADO POR LA SIGUIENTE FORMULA GENERAL (A) EN DONDE DOS DE R{SUB,A}, R{SUB,B} Y R{SUB,C} SON OXIGENO; X ES UN TIPO DE BENCILO, UN TIPO DE BENZOTIAZOLILMETILO, O UN TIPO DE NAFTILMETILO; R ES HIDROGENO O ALQUILO BAJO; N ES UN ENTERO DE 1 A 3; Y Z INDICA UN ENLACE DIRECTO O UNA MITAD DE UNION QUE CONTIENE UN ATOMO DE CARBONO. LOS COMPUESTOS ACTUAN COMO INHIBIDORES SELECTIVOS DE REDUCTASA DE ALDOSA. LOS COMPUESTOS PROVISTOS SON UTILES COMO FARMACOS PARA TERAPIA Y PREVENCION DE DIFERENTES TIPOS DE COMPLICACIONES DIABETICAS.
ES95120208T 1994-12-20 1995-12-20 Derivados heterociclicos carboxialquilicos. Expired - Lifetime ES2176277T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33582194 1994-12-20

Publications (1)

Publication Number Publication Date
ES2176277T3 true ES2176277T3 (es) 2002-12-01

Family

ID=18292789

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95120208T Expired - Lifetime ES2176277T3 (es) 1994-12-20 1995-12-20 Derivados heterociclicos carboxialquilicos.

Country Status (5)

Country Link
US (1) US5912261A (es)
EP (1) EP0718290B1 (es)
AT (1) ATE216368T1 (es)
DE (1) DE69526413T2 (es)
ES (1) ES2176277T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197806B1 (en) 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
JPH10182460A (ja) * 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd ３−デオキシグルコソン生成阻害剤
AU754989B2 (en) 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
JP4711523B2 (ja) 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
US7135492B2 (en) 2001-10-30 2006-11-14 Wyeth 1,3-disubstituted-2- thioxo-imidazolidine-4,5-dione derivatives useful in the treatment of atherosclerosis
US7115620B2 (en) 2001-10-30 2006-10-03 Wyeth 1,3-disubstituted-2-thioxo-imidazolidine-4,5-diones as potassium channel openers
TW200845994A (en) * 2007-01-12 2008-12-01 Smithkline Beecham Corp N-substituted glycine derivatives: prolyl hydroxylase inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32919A (en) * 1861-07-23 Cot or bedstead
US4099007A (en) * 1969-04-02 1978-07-04 Hoechst Aktiengesellschaft N,n-substituted 2,4,5-triketoimidazolidines and a process for their preparation
US3818031A (en) * 1971-03-26 1974-06-18 Ciba Geigy Corp Imidazolidinetrionecarboxylic acid derivatives
CH563711A5 (en) * 1972-03-03 1975-07-15 Ciba Geigy Ag Agents for regulating plant metabolism - contg. imidazolidine-2,4,5-trione-3-carboxylic acid derivs.
DE2612926A1 (de) * 1976-03-26 1977-10-06 Boehringer Mannheim Gmbh Neue acyl-derivate der 6-(alpha- amino-phenylacetamido)-penicillansaeure
AU578068B2 (en) * 1984-03-08 1988-10-13 Nippon Zoki Pharmaceutical Co., Ltd. Hydantoin derivatives and pharmaceutical compositions containing them
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
CA1265052A (en) * 1984-08-08 1990-01-30 Stanley J. Sarnoff Absorption enhancing agents
US4656034A (en) * 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents
US4658830A (en) 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
ATE50248T1 (de) * 1985-02-06 1990-02-15 Nippon Zoki Pharmaceutical Co Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
JP2567593B2 (ja) * 1986-12-29 1996-12-25 日本臓器製薬株式会社 イミダゾリジントリオン誘導体及び該化合物を有効成分として含有するアレルギ−性疾患治療剤
JPH01156965A (ja) * 1987-09-29 1989-06-20 Taiho Yakuhin Kogyo Kk チオヒダントイン化合物
US4904380A (en) * 1988-01-26 1990-02-27 Pall Corporation Precoat filter assembly
JP2544183B2 (ja) * 1988-07-29 1996-10-16 日本臓器製薬株式会社 新規パラバン酸誘導体及び該化合物を有効成分として含有する医薬組成物
JPH02225485A (ja) * 1989-02-27 1990-09-07 Taiho Yakuhin Kogyo Kk チエノピリミジン―３―酢酸誘導体
JP2678499B2 (ja) * 1989-08-09 1997-11-17 日本臓器製薬 株式会社 尿毒症毒素低下剤
AU3086095A (en) * 1994-07-29 1996-03-04 Suntory Limited Imidazolidine derivative and use thereof

Also Published As

Publication number Publication date
US5912261A (en) 1999-06-15
EP0718290B1 (en) 2002-04-17
DE69526413T2 (de) 2002-10-31
ATE216368T1 (de) 2002-05-15
EP0718290A1 (en) 1996-06-26
DE69526413D1 (de) 2002-05-23

Similar Documents

Publication Publication Date Title
ID22447A (id) Senyawa gula, bahan pengegel, komposisi bahan pengegel, proses penyediaannya serta komposisi gel
PT747374E (pt) Benzopiranos substituidos com sulfonamido activadores dos canais do potassio
EP1357115A4 (en) ALKANOIC ACID DERIVATIVES, PROCESS FOR THE PRODUCTION AND USE THEREOF
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
DE69918695D1 (de) Sauerstoffhaltige heterocyclische verbindungen
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
PT918776E (pt) Sintese total de acilfulvenos antitumorais
AU2124992A (en) Pharmaceutically useful indole derivatives
ES2176277T3 (es) Derivados heterociclicos carboxialquilicos.
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
KR900014388A (ko) 에세롤린의 카보네이트 유도체, 이의 제조방법 및 약제로서의 용도
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
ATE102937T1 (de) N-substituierte amid-derivate.
ATE275572T1 (de) Malto-oligosaccharid-derivate und ihre anwendungen
EP1375489A4 (en) MEDICINAL PREPARATION CONTAINING A 1,3-THIAZINE DERIVATIVE
ATE233739T1 (de) Neue parabansäure-derivate als aldose-reduktase inhibitoren
NO902017L (no) Organisk kjemisk forbindelse, flytende krystallmateriale inneholdende denne og flytende krystallinnretning inneholdende dette.
EP0401715A3 (en) Aminoketone compounds
ES2001166A6 (es) Procedimiento para preparar nuevos prostadienoatos
DE3867494D1 (de) Fluor enthaltende vitamin-d2-derivate.
GR3004321T3 (es)
DE69303847D1 (de) Indolderivate
LU88449I2 (fr) Fleroxacine et ses dérivés pharmaceutiquement acceptables.